IONIS PHARMACEUT reported $137.75M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Astellas Pharma 4503:JP Y 244955M 26313M
Biocryst Pharmaceuticals BCRX:US $ 49.68M 2.95M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Exelixis EXEL:US $ 342.78M 95.45M
Halozyme Therapeutics HALO:US $ 101.36M 20.94M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
Moderna Inc MRNA:US 5.05B 1.21B
Nektar Therapeutics NKTR:US $ 18.85M 0.76M
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Novartis NOVN:VX 9.06B 463M
Pfizer PFE:US $ 15651M 1516M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Ultragenyx Pharmaceutical RARE:US $ 73.83M 6.04M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M